| Literature DB >> 31599871 |
.
Abstract
Entities:
Keywords: Antiarrythmic Drugs; Beta-adrenergic blockers; Betapace; Brevibloc; Calan; Cardizem; Cartia; Catheter Ablation; Coreg; Corgard; Coumadin; DOAC; Digitek; Digox; Eliquis; Inderal; InnoPran; Isoptin; Kapspargo Sprinkle; Lanoxin; Lixiana; Lopressor; Mephyton; Multaq; NOAC ; Norpace; Pacerone; Pradaxa; Praxbind; Rate Control; Rhythm Control; Rythmol; Savaysa; Sotalol; Taztia; Tenormin; Tiazac; Tikosyn; Toprol; Verelan; Xarelto; adverse effects; amiodarone; andexanet alfa; anticoagulants; apixaban; atenolol; atrial fibrillation; beta blockers; bisoprolol; calcium-channel blockers; carvedilol; dabigatran; digoxin; diltiazem; disopyramide; dofetilide; dosage; dronedarone; drug interactions; edoxaban; efficacy; esmolol; flecainide; idarucizumab; metoprolol; nadolol; propafenone; propranolol; rivaroxaban; safety; sotalol; verapamil; vitamin K; warfarin; weight loss
Mesh：
Substances：
Year: 2019 PMID： 31599871
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN： 0025-732X Impact factor: 1.909